0001479290-18-000046 Sample Contracts

par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • March 13th, 2018 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York

Revance Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

Sample 1Sample 2Sample 3See All (489)
AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!